表紙
市場調查報告書

POC血液凝固檢查的全球市場:2019年∼2023年

Global POC Coagulation Testing Market 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 905967
出版日期 內容資訊 英文 124 Pages
訂單完成後即時交付
價格
Back to Top
POC血液凝固檢查的全球市場:2019年∼2023年 Global POC Coagulation Testing Market 2019-2023
出版日期: 2019年08月05日內容資訊: 英文 124 Pages
簡介

全球POC血液凝固檢查市場上,POC檢查裝置的採用擴大,抗凝固藥的大量消費,術前及術後篩檢的凝固監測的需求增加等成為成長促進因素,在預測期間內預計將以6%以上的年複合成長率擴大。但,血液凝固檢查的POC分析設備和試劑的高成本,POC血液凝固檢查產品相關的嚴格政府法規,及準確度的偏差相關疑慮等,可能妨礙在預測期間內POC血液凝固檢查產業的成長。

本報告提供全球POC血液凝固檢查市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2018年∼2023年)
  • 醫院、診療所
  • 居家照護
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • POC血液凝固檢查產品的自動化
  • 血液管理上POC血液凝固檢查的適用
  • 開發中國家的需求增加

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott Laboratories
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Medtronic Plc
  • Siemens Healthineers AG

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR31829

About this market

POC coagulation testing involves the use of portable and handheld coagulation testing devices that offer healthcare professionals and patients reliable and quick coagulation monitoring capabilities irrespective of their location. Technavio's POC coagulation testing market analysis considers sales from both homecare and hospitals and clinics. Our analysis also considers the sales of POC coagulation testing in Asia, Europe, North America, and ROW. In 2018, the hospitals and clinics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the use of POC coagulation testing analyzers during perioperative procedures will play a significant role in the hospitals and clinics segment to maintain its market position. Also, our global POC coagulation testing market report looks at factors such as the growing adoption of POC testing devices, significant consumption of anticoagulant drugs, and rising demand for coagulation monitoring in preoperative and postoperative screening. However, high cost of POC analyzers and reagents in coagulation testing, stringent government regulation on POC coagulation testing products, and concerns related to variability in accuracy and precision may hamper the growth of the POC coagulation testing industry over the forecast period.

Overview

Significant consumption of anticoagulant drugs

Anticoagulant drugs, also known as blood thinners, helps to reduce the chances of atrial fibrillation-related heart strokes by about 75%. The increasing consumption of these drugs is driving the need for coagulation testing procedures to monitor blood clotting. This demand will lead to the expansion of the global POC coagulation testing market at a CAGR of over 6% during the forecast period.

Automation in POC coagulation testing products

The development of automated POC coagulation testing products is increasing due to surging demand for faster turnaround times, automatic data uploading, and minimal human efforts. This has helped medical practitioners to perform rapid testing with minimal intervention. The automation in POC coagulation testing products is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global POC coagulation testing market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global POC coagulation testing market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC coagulation testing manufacturers, that include Abbott Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd., Medtronic Plc, and Siemens Healthineers AG.

Also, the POC coagulation testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals and clinics - Market size and forecast 2018-2023
  • Home care - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023

Key leading countries

  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Automation in POC coagulation testing products
  • Application of POC coagulation testing in blood management
  • Growing demand from developing economies

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Medtronic Plc
  • Siemens Healthineers AG

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

  • Exhibit 01: Product overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: End-user - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Hospitals and clinics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Hospitals and clinics - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Home care - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Home care - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by end-user
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2018-2023 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Abbott Laboratories - Vendor overview
  • Exhibit 45: Abbott Laboratories - Business segments
  • Exhibit 46: Abbott Laboratories - Organizational developments
  • Exhibit 47: Abbott Laboratories - Geographic focus
  • Exhibit 48: Abbott Laboratories - Segment focus
  • Exhibit 49: Abbott Laboratories - Key offerings
  • Exhibit 50: Danaher Corp. - Vendor overview
  • Exhibit 51: Danaher Corp. - Product segments
  • Exhibit 52: Danaher Corp. - Organizational developments
  • Exhibit 53: Danaher Corp. - Geographic focus
  • Exhibit 54: Danaher Corp. - Segment focus
  • Exhibit 55: Danaher Corp. - Key offerings
  • Exhibit 56: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 57: F. Hoffmann-La Roche Ltd. - Product segments
  • Exhibit 58: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 59: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 60: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 61: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 62: Medtronic Plc - Vendor overview
  • Exhibit 63: Medtronic Plc - Business segments
  • Exhibit 64: Medtronic Plc - Organizational developments
  • Exhibit 65: Medtronic Plc - Geographic focus
  • Exhibit 66: Medtronic Plc - Segment focus
  • Exhibit 67: Medtronic Plc - Key offerings
  • Exhibit 68: Siemens Healthineers AG - Vendor overview
  • Exhibit 69: Siemens Healthineers AG - Business segments
  • Exhibit 70: Siemens Healthineers AG - Organizational developments
  • Exhibit 71: Siemens Healthineers AG - Geographic focus
  • Exhibit 72: Siemens Healthineers AG - Segment focus
  • Exhibit 73: Siemens Healthineers AG - Key offerings
  • Exhibit 74: Validation techniques employed for market sizing
  • Exhibit 75: Definition of market positioning of vendors
Back to Top